Skip to main content

Table 3 Associations of SNPs in PTGS1 and ALOX12 2 and risk of rectal cancer stratified by fat and fatty acid intake

From: PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer

Gene

SNP

Fat/fatty acid

Genotype

Rectum fat/fatty acid intake

Low

Intermediate

High

ORa (95 % CI)

ORa (95 % CI)

ORa (95 % CI)

PTGS1

rs10306122 (2,125 T > C)

Total fat

AA

1.00

0.94 (0.69, 1.27)

1.12 (0.77, 1.62)

 

AG/GG

1.75 (1.02, 2.99)

1.22 (0.70, 2.11)

0.76 (0.46, 1.28)

p-interactiona

0.005

 

Adjusted p b

 

0.08

 

MUFA

AA

1.00

0.97 (0.71, 1.32)

1.15 (0.80, 1.67)

AG/GG

1.84 (1.07, 3.18)

1.03 (0.60, 1.77)

0.87 (0.51, 1.46)

p-interactiona

0.01

 

Adjusted p b

 

0.16

 

ALOX12

rs11571339 (7,135 A > G)

n-3

AA

1.00

1.14 (0.83, 1.57)

0.91 (0.64, 1.31)

 

AG/GG

0.47 (0.23, 0.93)

1.29 (0.77, 2.19)

1.05 (0.63, 1.73)

p-interactiona

0.046

 

Adjusted p b

 

0.79

 

18:02

AA

1.00

0.92 (0.66, 1.28)

0.89 (0.63, 1.27)

AG/GG

0.45 (0.21, 0.95)

0.90 (0.53, 1.55)

1.07 (0.66, 1.73)

p-interactiona

0.03

 

Adjusted p b

 

0.50

 

PUFA

AA

1.00

0.95 (0.69, 1.32)

0.87 (0.61, 1.23)

AG/GG

0.48 (0.23, 1.00)

0.87 (0.50, 1.49)

1.08 (0.67, 1.75)

p-interactiona

0.02

 

Adjusted p b

 

0.41

 
  1. Only SNPs with statistically significant interactions are shown
  2. Bold values are statistically significant
  3. aAdjusted for age, study center, ethnicity, sex, family history of disease, recent NSAID use (where appropriate), BMI, physical activity, dietary cholesterol, and caloric intake
  4. bBonferroni adjusted